Novel developments in biomarkers for FTD

Frontotemporal dementia (FTD) occurs when nerve cells in the frontal and temporal lobes of the brain are lost, causing the…

Date: 7th April 2022

Therapeutic plasma exchange to slow cognitive decline in Alzheimer’s disease

Therapeutic plasma exchange (TPE) is used to treat a variety of neurological, immunological, and metabolic disorders. The procedure removes patient…

Date: 3rd February 2022

Novel developments in biomarkers for FTD

Frontotemporal dementia (FTD) occurs when nerve cells in the frontal and temporal lobes of the brain are lost, causing the…

Date: 7th April 2022

Therapeutic plasma exchange to slow cognitive decline in Alzheimer’s disease

Therapeutic plasma exchange (TPE) is used to treat a variety of neurological, immunological, and metabolic disorders. The procedure removes patient…

Date: 3rd February 2022

Recent advances in plasma biomarkers for Alzheimer’s disease

In recent years, blood-based biomarkers have taken off in the dementia space, representing a less invasive, more cost-effective, and accessible…

Date: 2nd February 2022